COVADIS Microvascular Angina Diagnostic Criteria Calculator
Diagnostic criteria assessment
Assess each of the four COVADIS domains. Select the best-supported finding for the patient.
About the COVADIS criteria
The COVADIS framework standardizes the clinical and physiological assessment of microvascular angina in patients with suspected ischemia and non-obstructive coronary arteries (INOCA).
Diagnostic domains
| Criterion | Evidence considered |
|---|---|
| 1. Ischemic symptoms | Effort/rest angina or angina equivalents such as dyspnea. |
| 2. Non-obstructive CAD | Less than 50% epicardial diameter stenosis and/or FFR >0.80. |
| 3. Objective ischemia | Ischemic ECG changes or objective ischemia on functional testing. |
| 4. Microvascular dysfunction | Reduced CFR, abnormal microvascular resistance, microvascular spasm, or slow-flow evidence in established criteria. |
Classification logic used
- Definite MVA: all four criteria are present.
- Suspected MVA: criteria 1 and 2 are present, with either criterion 3 or criterion 4 present, but not both.
- Criteria not fulfilled: the required combination is absent.
- Incomplete assessment: available information is insufficient to classify reliably.
The suspected/definite classification logic is based on the established COVADIS framework described in the 2018 standardization paper and subsequent guideline summaries. The 2026 update abstract confirms the four diagnostic domains; detailed revised classification wording should be checked against the full publication when accessible.
Clinical considerations
- Interpret CFR using the validated threshold for the specific measurement technique and laboratory protocol; published thresholds vary approximately from 2.0 to 2.5.
- An IMR of 25 or greater is commonly used as evidence of increased microvascular resistance in invasive physiology protocols.
- Microvascular spasm requires reproduction of symptoms and ischemic ECG changes during acetylcholine testing without epicardial spasm.
- Exclude or consider alternative explanations, including epicardial vasospasm, diffuse epicardial disease, and heart failure with preserved ejection fraction where clinically relevant.
- This checklist supports structured assessment and does not replace comprehensive coronary functional testing or clinical judgment.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.